tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market
APVO
Aptevo Therapeutics
RESEARCH TOOLSreports

Aptevo Therapeutics (APVO) Financial Statements

Compare
742 Followers

Aptevo Therapeutics Financial Overview

Aptevo Therapeutics's market cap is currently $4.50M. The company's EPS TTM is $-5.911; its P/E ratio is >-0.01; Aptevo Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 3.11M$ 12.29M
Gross Profit$ 0.00$ -352.00K$ 0.00$ 3.11M$ 12.29M
Operating Income$ -26.31M$ -24.60M$ -28.88M$ -28.64M$ -21.40M
EBITDA$ -26.31M$ -23.78M$ -28.31M$ -27.74M$ -20.26M
Net Income$ -27.54M$ -24.13M$ -17.41M$ 8.03M$ -28.46M
Balance Sheet
Cash & Short-Term Investments$ 21.62M$ 8.71M$ 16.90M$ 22.64M$ 45.04M
Total Assets$ 27.19M$ 15.59M$ 24.84M$ 34.22M$ 56.60M
Total Debt$ 4.63M$ 4.63M$ 5.40M$ 9.54M$ 16.71M
Net Debt$ -16.99M$ -4.08M$ -11.51M$ -13.10M$ -28.33M
Total Liabilities$ 9.81M$ 10.84M$ 12.62M$ 16.24M$ 55.38M
Stockholders' Equity$ 17.38M$ 4.75M$ 12.22M$ 17.97M$ 1.22M
Cash Flow
Free Cash Flow$ -25.59M$ -23.79M$ -11.73M$ -21.05M$ -22.39M
Operating Cash Flow$ -25.59M$ -23.79M$ -11.73M$ -21.02M$ -21.68M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -29.00K$ -713.00K
Financing Cash Flow$ 38.50M$ 15.60M$ 6.00M$ -2.62M$ 26.16M
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Income Statement >

Aptevo Therapeutics Debt to Assets

Balance Sheet >

Aptevo Therapeutics Cash Flow

Cash Flow >

Aptevo Therapeutics Forecast EPS vs Actual EPS

Earnings >